NSW BioCheers with McCullough Robertson
.png?version=380D0807)
Join us in Sydney on 30 July and catch up with friends and colleagues, share ideas, build relationships and make new contacts in the vibrant NSW biotechnology community.
This NSW BioCheers will be an evening of connection, conversation and insights, featuring Kerri Lee Sinclair, Director of Investment at AusBiotech, for a special Capital Conversation. Hear perspectives on the investment landscape, capital pathways and opportunities shaping Australia’s life sciences sector, while networking with peers across the biotech community.
This event is generously hosted by McCullough Robertson
| Date: |
Thursday 30 July 2026 |
Time:
(AEST) |
5:00 – 5:30pm Registrations open
5:30 – 5:45pm Welcome address and AusBiotech Capital Conversation
5:45 – 7:30pm BioCheers Networking Function
|
|
|
(space) |
(space)
|
|
|
| (pace) |
(space) |
| Venue: |
McCullough Robertson Offices
Level 32, 25 Martin Place,
Sydney, NSW 2000
|
| (space) |
(space) |
| Cost: |
AusBiotech Members: Free
|
Speaker
.png) |
Kerri Lee Sinclair, Director of Investment, AusBiotech
Kerri Lee Sinclair is Director of Investment at AusBiotech, where she leads investment strategy to strengthen investor engagement and capital formation across Australia’s life sciences sector. She works across industry, investor and international networks to enhance Australia’s profile as a destination for life sciences investment, drawing on experience across innovation, entrepreneurship, investment and global operating roles.
|
Event Partner
.png)
McCullough Robertson is a leading independent full service Australian law firm advising national and international clients across every State and Territory. For nearly 100 years, major corporations, financial institutions, governments and high net worth individuals have trusted us with their most critical legal matters, valuing our combination of technical excellence, commercial insight and a genuinely down-to-earth approach.
We have one of the largest life sciences teams in Australia, including lawyers with science qualifications who bring deep technical understanding to complex commercial and regulatory issues. We support life sciences companies, emerging ventures, universities and research institutes across the full innovation lifecycle, advising on IP protection and commercialisation, M&A and capital raising, clinical trials, and regulatory and commercial issues spanning drug development, diagnostics, medical devices, eHealth, agtech, animal health, wearable devices and other regulated products.
Not a member?
Contact our Memberships Team on [email protected] to find out more about AusBiotech membership benefits.
*Members if you are experiencing issues registering for the event, please contact our Memberships Team, on [email protected] who will help.
Registration
Due to high demand and limited capacity for our BioCheers and BioBriefing events, we are opening registrations to members first, with non-member registrations opening on demand and subject to availability.
Registration
Registration ends 29/07/2026 5:00 PM AUSEST